ONABOTULINUMTOXINA PROVIDES EARLY AND CONSISTENT IMPROVEMENTS IN OVERACTIVE BLADDER SYMPTOMS AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER

被引：0
|
作者：
McCammon, Kurt
Kohan, Alfred
Kaminetsky, Jed
Gousse, Angelo
Gruenenfelder, Jennifer
Orejudos, Amelia
Aboushwareb, Tamer
MacDiarmid, Scott
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.1218
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD26-10
引用
收藏
页码：E510 / E510
页数：1
相关论文
共 50 条
  • [31] Correlation Between Improvements in Overactive Bladder Symptom Score and Health-Related Quality of Life Questionnaires in Overactive Bladder Patients Treated With an Antimuscarinic Drug
    Kubota, Yasue
    Kojima, Yoshiyuki
    Shibata, Yasuhiro
    Imura, Makoto
    Kohri, Kenjiro
    Sasaki, Shoichi
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (07) : 1309 - 1314
  • [32] MANAGING OVERACTIVE BLADDER Overactive bladder symptoms have a variety of causes
    Dickson, Malcolm John
    Anders, Nicola R. K.
    Cox, Sam
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [33] Selected outcomes in patients with overactive bladder compared to non-overactive bladder controls
    Daniel, G
    Kamat, SA
    Brewer, K
    Bullano, MF
    Telly, T
    Williamson, T
    VALUE IN HEALTH, 2005, 8 (03) : 413 - 413
  • [34] LOW INCIDENCE OF CLEAN INTERMITTENT CATHETERISATION WITH ONABOTULINUMTOXINA IN DIVERSE AGE GROUPS OF OVERACTIVE BLADDER PATIENTS WITH CORRESPONDING IMPROVEMENTS IN URINARY SYMPTOMS, TREATMENT RESPONSE, AND QUALITY OF LIFE
    Nitti, V
    Drake, M.
    Everaert, K.
    Rovner, E.
    Dmochowski, R.
    Ginsberg, D.
    Radomski, S.
    Aboushwareb, T.
    Chang, C.
    Chapple, C.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S300 - S301
  • [35] OnabotulinumtoxinA for Idiopathic Overactive Bladder Symptoms: Many Answers but More Questions
    Madersbacher, Stephan
    EUROPEAN UROLOGY, 2013, 64 (02) : 257 - 259
  • [36] CAN ONABOTULINUMTOXINA IMPROVE SYMPTOMS AND QUALITY OF LIFE IN ALL PATIENTS WITH OVERACTIVE BLADDER, REGARDLESS OF DISEASE DURATION OR BODY MASS INDEX?
    Chermansky, C.
    Rechberger, T.
    Miles-Thomas, J.
    Hale, D.
    Cardozo, L.
    Orejudos, A.
    Patel, A.
    Herschorn, S.
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S219 - S220
  • [37] OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
    Chapple, Christopher
    Sievert, Karl-Dietrich
    MacDiarmid, Scott
    Khullar, Vik
    Radziszewski, Piotr
    Nardo, Christopher
    Thompson, Catherine
    Zhou, Jihao
    Haag-Molkenteller, Cornelia
    EUROPEAN UROLOGY, 2013, 64 (02) : 249 - 256
  • [38] ONABOTULINUMTOXINA SIGNIFICANTLY REDUCES URINARY INCONTINENCE AND IMPROVES QUALITY OF LIFE IN FEMALE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER
    Khullar, V.
    Sand, P.
    Parsons, M.
    Zhou, J.
    Globe, D.
    Nardo, C.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 : S13 - S14
  • [39] The treatment of overactive bladder syndrome with onabotulinumtoxinA therapy
    Majoros Attila
    Romics Miklos
    Ali Aida
    Hamvas Antal
    Molnar Peter Jozsef
    Keszthelyi Attila
    Nyirady Peter
    ORVOSI HETILAP, 2021, 162 (36) : 1459 - 1465
  • [40] Efficacy of fesoterodine in patients with overactive bladder (OAB): Improvements in oab symptoms and health-related quality of life (HRQL)
    Chapple, Christopher
    Van Kerrebroeck, Philip
    Tubaro, Andrea
    Wang, Joseph T.
    Hvidsten, Kyle
    Brodsky, Marina
    JOURNAL OF UROLOGY, 2007, 177 (04): : 392 - 392
12345